News | News By Subject | News by Disease News By Date | Search News

Coronary artery angioplasty News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Alchemia Release: Arixtra(R) Receives Priority Review By The FDA In Acute Coronary Syndromes (ACS)     10/4/2006
FDA Issues Public Health Advisory For Bayer AG (BAY)'s Trasylol; Drug Linked To Higher Risks Of Serious Side Effects     2/8/2006
Alexion Pharmaceuticals Inc. (ALXN) Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations     11/23/2005
Medtronic, Inc. (MDT) Stent Misses Target     10/17/2005
CV Therapeutics, Inc. (CVTX) Release: Ranexa(TM) (ranolazine) Meets Primary Endpoint In Approval-Enabling ERICA Study; Stocks Surge     4/18/2005
American BioScience, Inc. Presents Clinical Trial Results Of The First Human Study Of Coroxane(TM) For The Treatment Of Restenosis At The Cardiovascular Revascularization Therapies (CRT) Conference     4/5/2005
Corgentech, Inc. (CGTK) And Bristol-Myers Squibb Company (BMY) Announce Results From Edifoligide (E2F Decoy) Phase 3 Trial For Coronary Artery Bypass Graft Failure; Failed To Meet The Trial's Primary And Secondary Endpoints     3/30/2005
TyRx Pharma Inc. Announces Equity Investment By Boston Scientific Corporation (BSX)     2/1/2005
Ariad Pharmaceuticals, Inc. (ARIA) Announces Collaboration With Medinol Ltd., Stent Technology Leader, To Develop AP23573 Drug-Delivery Stents     1/27/2005
Edwards Lifesciences (EW) Realigns Its Japan Business     1/27/2005
Abbott Laboratories (ABT) Announces Groundbreaking New Trial In Stroke Prevention     1/18/2005
Boston Scientific Corporation (BSX) Exercises Right To Obtain Exclusive Paclitaxel License From Angiotech Pharmaceuticals (ANPI)     11/23/2004

News from Around the Web

Press Releases
The Medicines Company (MDCO) Angiox(R) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality     9/4/2007
BusinessWeek Article Highlights Cardiovascular BioTherapeutics, Inc. (CVBT.OB) for Developing a Promising Protein Therapy to Treat Coronary Artery Disease     7/6/2007
GlaxoSmithKline (GSK) Release: FDA Grants Priority Review For ARIXTRA(R) (fondaparinux sodium) In The Treatment Of Acute Coronary Syndromes     10/2/2006
Cytori Therapeutics, Inc. (CYTX) Reports Safety And Efficacy Of Its Celution System(TM) In A Preclinical Study Of Coronary Artery Disease     7/17/2006
Ranbaxy Pharmaceuticals Inc. Receives FDA Approval To Market Simvastatin 80mg Tablets With 180-Day Exclusivity     6/26/2006
diaDexus Release: New Data Published In An American Heart Association Journal Shows That Lipoprotein-Associated Phospholipase A2 Independently Adds To The Diagnostic Accuracy Of Traditional Risk Assessment For Future Cardiovascular Events     6/26/2006
Medtronic, Inc. (MDT) Receives FDA Approval For Micro-Driver Stent     5/1/2006
Neuren Pharmaceuticals Limited Announces Successful Phase 2 Results For Its Lead Candidate Glypromate(R)     4/13/2006
Teva Pharmaceutical Industries Limited (TEVA) Receives Favorable Court Ruling On Generic Pravachol(R) Exclusivity     10/21/2005
Johnson & Johnson (JNJ) Advised By Canadian Competition Bureau On Proposed Acquisition Of Guidant Corporation (GDT)     9/2/2005
Vascular Solutions (VASC) Gets FDA Device OK     8/17/2005
Terumo Corporation Completes Twentieth Case Of DuraHeart Artificial Heart Implantation     7/26/2005
Singapore-Listed Biosensors International Obtains CE Mark Approval For Axxion Drug-Eluting Stent     7/12/2005
Alexion Pharmaceuticals Inc. (ALXN) Reports Results Of Eculizumab Extension Trial In PNH In The Journal Blood     6/29/2005
Scott And Scott, LLC Files Initial Securities Fraud Class Action Lawsuit Against Guidant Corporation (GDT)     6/27/2005